Regeneron Pharmaceuticals (REGN) Buildings (2010 - 2017)

Regeneron Pharmaceuticals' Buildings history runs 6 years deep, the most recent figure standing at $1.4 billion for Q4 2017.

• In Q4 2017, Buildings rose 12.77% year-over-year to $1.4 billion; the TTM figure through Dec 2017 stood at $1.4 billion (up 12.77% YoY), while the FY2017 annual figure was $1.4 billion, up 12.77% from the prior year.
• Buildings was $1.4 billion for Q4 2017 at Regeneron Pharmaceuticals, up from $1.3 billion in the prior quarter.
• In the past five years, Buildings ranged from a high of $1.4 billion in Q4 2017 to a low of $343.4 million in Q4 2013.
• Historically, Buildings has averaged $844.5 million across 5 years, with a median of $760.5 million in 2015.
• The sharpest annual moves came in 2015 and 2017: Buildings surged 90.61% in 2015, then increased 12.77% in 2017.
• A 5-year view of Buildings shows it stood at $343.4 million in 2013, then grew by 16.2% to $399.0 million in 2014, then soared by 90.61% to $760.5 million in 2015, then jumped by 68.08% to $1.3 billion in 2016, then rose by 12.77% to $1.4 billion in 2017.
• The last three Buildings figures came in at $1.4 billion (Q4 2017), $1.3 billion (Q4 2016), and $760.5 million (Q4 2015), per Business Quant data.